Company Overview of NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics for patients suffering from central nervous system (CNC) disorders. The company focuses on developing a pipeline of compounds and medicines for the treatment of neuropathic pain, inflammatory pain, acute pain, epilepsy, anxiety, autism, migraine, schizophrenia, and bipolar. Its lead product NTP-2014 is a molecule compound that has applications in various diseases, including epilepsy, pain, and other CNS indications. The company was incorporated in 2006 and is based in Chicago, Illinois.
8750 West Bryn Mawr Avenue
Chicago, IL 60631
Founded in 2006
Key Executives for NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. Key Developments
Similar Private Companies By Industry
|Lifeblood Biological Services, LLC||United States|
|Nutraceutics Corp.||United States|
|Hogil Pharmaceutical Corp.||United States|
|Bigmar Inc.||United States|
|Access Product Marketing, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Bridgewater, NJ | InformaticaPosted: Dec 11
- Princeton, NJ | RGPPosted: Dec 13
- Princeton, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact NeuroTherapeutics Pharma, Inc., please visit www.ntprx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.